pubmed-article:15592332 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15592332 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:15592332 | lifeskim:mentions | umls-concept:C0995150 | lld:lifeskim |
pubmed-article:15592332 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
pubmed-article:15592332 | lifeskim:mentions | umls-concept:C0743223 | lld:lifeskim |
pubmed-article:15592332 | lifeskim:mentions | umls-concept:C1880177 | lld:lifeskim |
pubmed-article:15592332 | lifeskim:mentions | umls-concept:C0105755 | lld:lifeskim |
pubmed-article:15592332 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:15592332 | pubmed:dateCreated | 2004-12-13 | lld:pubmed |
pubmed-article:15592332 | pubmed:abstractText | Our objectives were to evaluate the contribution of bergamottin to the grapefruit juice-felodipine interaction and to characterize bergamottin disposition. | lld:pubmed |
pubmed-article:15592332 | pubmed:language | eng | lld:pubmed |
pubmed-article:15592332 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15592332 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15592332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15592332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15592332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15592332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15592332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15592332 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15592332 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15592332 | pubmed:month | Dec | lld:pubmed |
pubmed-article:15592332 | pubmed:issn | 0009-9236 | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:NAOYY | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:HollenbergPau... | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:BaileyDavid... | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:GoosenTheunis... | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:CohenLucindaL | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:WilliamsJ... | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:WosterPatrick... | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:YuChongwooC | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:CilliéDoréD | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:RheedersMalie... | lld:pubmed |
pubmed-article:15592332 | pubmed:author | pubmed-author:DijkstraH... | lld:pubmed |
pubmed-article:15592332 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15592332 | pubmed:volume | 76 | lld:pubmed |
pubmed-article:15592332 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15592332 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15592332 | pubmed:pagination | 607-17 | lld:pubmed |
pubmed-article:15592332 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:meshHeading | pubmed-meshheading:15592332... | lld:pubmed |
pubmed-article:15592332 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15592332 | pubmed:articleTitle | Bergamottin contribution to the grapefruit juice-felodipine interaction and disposition in humans. | lld:pubmed |
pubmed-article:15592332 | pubmed:affiliation | Department of Pharmacology, North-West University, Potchefstroom. theunis.goosen@pfizer.com | lld:pubmed |
pubmed-article:15592332 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15592332 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15592332 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15592332 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15592332 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15592332 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15592332 | lld:pubmed |